Spyre Therapeutics (SYRE) Preferred Shares (2015 - 2026)
Spyre Therapeutics (SYRE) reported Preferred Shares of $146.43 million for Q3 2026, down 6.0% from $155.82 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Preferred Shares (2015 - 2026) Analysis & Trends
At the end of FY2025, Spyre Therapeutics posted Preferred Shares of $155.82 million, unchanged from FY2024.
- By year, Preferred Shares came in at $155.82 million in FY2024 (-15.7%) and $184.93 million in FY2023.
- Five-year quarterly Preferred Shares spans a low of $146.43 million in Q2 2026 and a high of $184.93 million in Q1 2024.
- Over the past five years, the year-over-year decline in Preferred Shares ranged from 0.0% (Q1 2026) to 15.7% (Q4 2024).
- Per Business Quant data, the three quarters before Q3 2026 came in at $146.43 million (Q2 2026), $155.82 million (Q1 2026) and $155.82 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 146.43 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 146.43 Mn |
| Jun 30, 2026 | 146.43 Mn |
| Mar 31, 2026 | 155.82 Mn |
| Dec 31, 2025 | 155.82 Mn |
| Sep 30, 2025 | 155.82 Mn |
| Jun 30, 2025 | 155.82 Mn |
| Mar 31, 2025 | 155.82 Mn |
| Dec 31, 2024 | 155.82 Mn |
| Sep 30, 2024 | 155.82 Mn |
| Jun 30, 2024 | 155.82 Mn |
| Mar 31, 2024 | 184.93 Mn |
| Dec 31, 2023 | 184.93 Mn |
| Dec 31, 2016 | 44.74 Mn |
| Sep 30, 2016 | 44.74 Mn |
| Jun 30, 2016 | 44.74 Mn |
| Mar 31, 2016 | 44.74 Mn |
| Dec 31, 2015 | 58.30 Mn |
API Access
Spyre Therapeutics Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();